XML 46 R31.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2024
Stockholders' Equity  
Schedule of warrants issued and outstanding

The following table presents information about warrants that are issued and outstanding at December 31, 2024:

Year Issued

    

Equity Instrument

    

Warrants Outstanding

    

Exercise Price

    

Date of Expiration

2023 (1)

Common Stock

6,796,280

$

8.03

10/16/2028

Total

 

  

 

6,796,280

 

  

 

  

Weighted average exercise price

 

  

 

  

$

8.03

 

  

Weighted average life in years

 

  

 

  

 

  

 

3.79

(1) 1,571,093 pre-funded warrants were issued in 2023 with an exercise price of $0.001 per share and are exercisable until all pre-funded warrants are exercised in full. 1,571,093 pre-funded warrants were outstanding as of December 31, 2024 and are not included in the table above.

Schedule of reserved for future issuance

December 31, 

December 31, 

    

2024

    

2023

Reserved under the 2015 Second Amended and Restated Stock Incentive Plan and the 2022 Inducement Stock Incentive Plan

 

8,849,170

 

5,334,301

Warrants for the purchase of common stock

8,367,373

9,271,689

Options outstanding to purchase common stock

 

6,850,889

 

3,553,969

Series X Preferred Stock

 

5,184,591

 

5,184,591

Reserved under the employee stock purchase plan

49,139

43,060

Total

 

29,301,162

 

23,387,610